Pages that link to "Q45883842"
Jump to navigation
Jump to search
The following pages link to Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment (Q45883842):
Displaying 50 items.
- Combination bacteriolytic therapy for the treatment of experimental tumors (Q24555050) (← links)
- Can engineered bacteria help control cancer? (Q24555059) (← links)
- Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations (Q24801771) (← links)
- Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress (Q26745551) (← links)
- High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting (Q27309184) (← links)
- Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery (Q28084076) (← links)
- Exploring the link between microorganisms and oral cancer: a systematic review of the literature (Q28246561) (← links)
- Exploiting tumour hypoxia in cancer treatment (Q28264146) (← links)
- Hypoxia--a key regulatory factor in tumour growth (Q29547318) (← links)
- Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium (Q30491729) (← links)
- Genome sequence of Clostridium sporogenes DSM 795(T), an amino acid-degrading, nontoxic surrogate of neurotoxin-producing Clostridium botulinum (Q30659248) (← links)
- Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo (Q33688369) (← links)
- The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene (Q33691013) (← links)
- Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors (Q33704231) (← links)
- Taking polycation gene delivery systems from in vitro to in vivo. (Q33724293) (← links)
- HIF-1alpha: a valid therapeutic target for tumor therapy (Q33746822) (← links)
- Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium (Q33756746) (← links)
- Use of preferentially replicating bacteria for the treatment of cancer (Q33895307) (← links)
- Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer (Q33925546) (← links)
- Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors (Q34025073) (← links)
- Can gene therapy overcome the problem of hypoxia in radiotherapy? (Q34157875) (← links)
- Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins (Q34301980) (← links)
- Clostridia in cancer therapy (Q34307573) (← links)
- Use of bacteria as anticancer agents (Q34452077) (← links)
- Hypoxia as a target for combined modality treatments. (Q34501934) (← links)
- Oncolytic biotherapy: a novel therapeutic plafform (Q34571752) (← links)
- Vessel destruction by tumor-targetingSalmonella typhimuriumA1-R is enhanced by high tumor vascularity (Q34620886) (← links)
- Tumor hypoxia in cancer therapy (Q34712834) (← links)
- Bugs as drugs for cancer. (Q34842154) (← links)
- Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium (Q34988082) (← links)
- Bacteria as tumour-targeting vectors (Q35215803) (← links)
- Proliferation behavior of E. coli in a three-dimensional in vitro tumor model (Q35708412) (← links)
- Photodynamic Treatment of Tumor with Bacteria Expressing KillerRed (Q35715746) (← links)
- Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer (Q35840470) (← links)
- Hypoxia in head and neck cancer: how much, how important? (Q36160990) (← links)
- Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. (Q36191597) (← links)
- Effect of Heat-Inactivated Clostridium sporogenes and Its Conditioned Media on 3-Dimensional Colorectal Cancer Cell Models (Q36216216) (← links)
- Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems. (Q36495546) (← links)
- Therapeutic efficacy of tumor-targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse models (Q36544581) (← links)
- Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model. (Q36561606) (← links)
- The use of clostridial spores for cancer treatment. (Q36565145) (← links)
- Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo (Q36611812) (← links)
- Regulation of angiogenesis by hypoxia and hypoxia-inducible factors (Q36659549) (← links)
- Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors (Q36675446) (← links)
- Tumor hypoxia and targeted gene therapy (Q36729104) (← links)
- Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104. (Q37001301) (← links)
- A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer (Q37288950) (← links)
- Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. (Q37424066) (← links)
- Microbial-based therapy of cancer: current progress and future prospects (Q37843621) (← links)
- Bacterial spores as platforms for bioanalytical and biomedical applications (Q37850353) (← links)